These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 12392580)

  • 1. Receptor pharmacogenetics: relevance to CNS syndromes.
    Shaikh S; Kerwin RW
    Br J Clin Pharmacol; 2002 Oct; 54(4):344-8. PubMed ID: 12392580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Applications of pharmacogenetics in psychiatry: personalisation of treatment.
    Arranz MJ; Munro J; Osborne S; Collier D; Kerwin RW
    Expert Opin Pharmacother; 2001 Apr; 2(4):537-42. PubMed ID: 11336604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Receptor polymorphism and response to treatment in schizophrenia].
    Szekeres G; Janka Z
    Orv Hetil; 2002 Sep; 143(35):2027-33. PubMed ID: 12387196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain neurotransmitter transporter/receptor genomics and efavirenz central nervous system adverse events.
    Haas DW; Bradford Y; Verma A; Verma SS; Eron JJ; Gulick RM; Riddler SA; Sax PE; Daar ES; Morse GD; Acosta EP; Ritchie MD
    Pharmacogenet Genomics; 2018 Jul; 28(7):179-187. PubMed ID: 29847509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurotransmitter receptor variants and their influence on antipsychotic treatment (Review)).
    Arranz MJ; Mancama D; Kerwin RW
    Int J Mol Med; 2001 Jan; 7(1):27-30. PubMed ID: 11115604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurotransmitter-related genes and antipsychotic response: pharmacogenetics meets psychiatric treatment.
    Arranz MJ; Kerwin RW
    Ann Med; 2000 Mar; 32(2):128-33. PubMed ID: 10766404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacogenetics for the individualization of psychiatric treatment.
    Arranz MJ; Collier D; Kerwin RW
    Am J Pharmacogenomics; 2001; 1(1):3-10. PubMed ID: 12173312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacogenomics in psychiatry: the relevance of receptor and transporter polymorphisms.
    Reynolds GP; McGowan OO; Dalton CF
    Br J Clin Pharmacol; 2014 Apr; 77(4):654-72. PubMed ID: 24354796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacogenetics and pharmacogenomics of schizophrenia: a review of last decade of research.
    Arranz MJ; de Leon J
    Mol Psychiatry; 2007 Aug; 12(8):707-47. PubMed ID: 17549063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reward deficiency syndrome: genetic aspects of behavioral disorders.
    Comings DE; Blum K
    Prog Brain Res; 2000; 126():325-41. PubMed ID: 11105655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of pharmacogenetics in treating central nervous system disorders.
    Patnaik M; Renda MJ; Athanasiou MC; Reed CR
    Exp Biol Med (Maywood); 2008 Dec; 233(12):1504-9. PubMed ID: 18849543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review lecture. Neurotransmitters and trophic factors in the autonomic nervous system.
    Burnstock G
    J Physiol; 1981; 313():1-35. PubMed ID: 6115939
    [No Abstract]   [Full Text] [Related]  

  • 13. Central/nervous system/neuromuscularchannelopathies.
    Zuberi SM
    Eur J Paediatr Neurol; 2001; 5(5):207-9. PubMed ID: 11585110
    [No Abstract]   [Full Text] [Related]  

  • 14. Potential role of neural peptides in CNS genetic disorders.
    Caviness VS
    Adv Biochem Psychopharmacol; 1981; 28():645-56. PubMed ID: 6111183
    [No Abstract]   [Full Text] [Related]  

  • 15. Dopamine receptor polymorphisms and drug response in schizophrenia.
    Scharfetter J
    Pharmacogenomics; 2001 Aug; 2(3):251-61. PubMed ID: 11535113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autonomic neurotransmitters and trophic factors.
    Burnstock G
    J Auton Nerv Syst; 1983; 7(3-4):213-7. PubMed ID: 6135728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Neuroleptic parkinsonism and tardive dyskinesia and methods of pharmacologically correcting these pathologic conditions (review)].
    Arushanian EB
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1985; 85(2):269-77. PubMed ID: 2858951
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacogenetics of antidepressants and antipsychotics: the contribution of allelic variations to the phenotype of drug response.
    Kirchheiner J; Nickchen K; Bauer M; Wong ML; Licinio J; Roots I; Brockmöller J
    Mol Psychiatry; 2004 May; 9(5):442-73. PubMed ID: 15037866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Changes in functional interrelations of neuromediator systems during aging and the development of neuropsychological pathology of old age (review)].
    Burchinskiĭ SG
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1985; 85(9):1394-1400. PubMed ID: 2866651
    [No Abstract]   [Full Text] [Related]  

  • 20. Behavioral correlates of presynaptic events in the cholinergic neurotransmitter system.
    Russell RW
    Prog Drug Res; 1988; 32():43-130. PubMed ID: 2905821
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.